Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens

FEMS Microbiology Reviews

Volumn 28, Issue 4, 2004, Pages 405-440

  Servin, Alain L ^a  

^a INSERM   (France)

Author keywords

Antimicrobials; Bifidobacteria; Bowel disease; Diarrhea; Gastrointestinal pathogens; H. pylori infection; Lactobacilli

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; ANTIMICROBIAL CATIONIC PEPTIDE; ATCC 15696; BL 2928; CLARITHROMYCIN; COLICIN; CTC 2197; CYC 10051; CYC 10058; DEFENSIN; DR 20; HN 001; HN 017; HN 019; INTERLEUKIN 1; INTERLEUKIN 12; INTERLEUKIN 6; JCM 5810; LC 705; LCR 35; N (1 DEOXYFRUCTOS 1 YL)DAUNORUBICIN; PROBIOTIC AGENT; RABEPRAZOLE; RUMINOCOCCIN A; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNINDEXED DRUG; UO 001; UO 002; YIT 4064;

ANTIMICROBIAL ACTIVITY; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIUM ADHERENCE; BIFIDOBACTERIUM; COLONY FORMING UNIT; DIARRHEA; DIGESTIVE SYSTEM; DRUG SAFETY; ECOSYSTEM; ENTERITIS; ENTEROBACTER INFECTION; EPITHELIUM; ESCHERICHIA COLI; EXOCYTOSIS; GASTROENTERITIS; GASTROINTESTINAL TRACT; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HOST RESISTANCE; HUMAN; IMMUNE SYSTEM; IMMUNOMODULATION; INTESTINE FLORA; INTESTINE FUNCTION; LACTOBACILLUS; LISTERIA MONOCYTOGENES; LISTERIOSIS; MOLECULE; NONHUMAN; PHENOTYPE; REVIEW; ROTAVIRUS; SALMONELLA; SALMONELLOSIS; SIDE EFFECT; SIGNAL TRANSDUCTION; URINARY TRACT INFECTION; VAGINITIS; VIRUS INFECTION;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIBIOSIS; BACTERIA; BACTERIAL ADHESION; BACTERIAL INFECTIONS; BIFIDOBACTERIUM; GASTROINTESTINAL DISEASES; GASTROINTESTINAL TRACT; HUMANS; HYDROGEN PEROXIDE; LACTOBACILLUS; ROTAVIRUS; ROTAVIRUS INFECTIONS; SURFACE-ACTIVE AGENTS; URINARY TRACT INFECTIONS;

MICROBIOTA;

EID: 4444242774     PISSN: 01686445     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.femsre.2004.01.003     Document Type: Review

References (437)

1. Savage D.C. Microbial ecology of the gastrointestinal tract. Annu. Rev. Microbiol. 31:1977;107-133
2. Mackie R.I., Sghir A., Gaskins H.R. Developmental microbial ecology of the neonatal gastrointestinal tract. Am. J. Clin. Nutr. 69:1999;1035S-1045S
3. Mccracken V.J., Lorenz R.G. The gastrointestinal ecosystem: a precarious alliance among epithelium, immunity and microbiota. Cell. Microbiol. 3:2001;1-11
4. Berg R.D. The indigenous gastrointestinal microflora. Trends Microbiol. 4:1996;430-435
5. Morelli L., Cesena C., De Haen C., Gozzini L. Taxonomic Lactobacillus composition of feces from human newborns during the first few days. Microb. Ecol. 35:1998;205-212
6. Vaughan E.E., Schut F., Heilig H.G., Zoetendal E.G., De Vos W.M., Akkermans A.D. A molecular view of the intestinal ecosystem. Curr. Issues Intest. Microbiol. 1:2000;1-12
7. Zboril V. Physiology of microflora in the digestive tract. Vnitr. Lek. 48:2002;17-21
8. Roach S., Savage D.C., Tannock G.W. Lactobacilli isolated from the stomach of conventional mice. Appl. Environ. Microbiol. 33:1977;1197-1203
9. Uribe A., Alam M., Johansson O., Midtvedt T., Theodorsson E. Microflora modulates endocrine cells in the gastrointestinal mucosa of the rat. Gastroenterology. 107:1994;1259-1269
10. Bry L., Falk P.G., Midtvedt T., Gordon J.I. A model of host-microbial interactions in an open mammalian ecosystem. Science. 273:1996;1380-1383
11. Falk P.G., Hooper L.V., Midtvedt T., Gordon J.I. Creating and maintaining the gastrointestinal ecosystem: what we know and need to know from gnotobiology. Microbiol. Mol. Biol. Rev. 62:1998;1157-1170
12. Hooper L.V., Xu J., Falk P.G., Midtvedt T., Gordon J.I. A molecular sensor that allows a gut commensal to control its nutrient foundation in a competitive ecosystem. Proc. Natl. Acad. Sci. USA. 96:1999;9833-9838
13. Putsep K., Axelsson L.G., Boman A., Midtvedt T., Normark S., Boman H.G., Andersson M. Germ-free and colonized mice generate the same products from enteric prodefensins. J. Biol. Chem. 275:2000;40478-40482
14. Lopez-Boado Y.S., Wilson C.L., Hooper L.V., Gordon J.I., Hultgren S.J., Parks W.C. Bacterial exposure induces and activates matrilysin in mucosal epithelial cells. J. Cell. Biol. 148:2000;1305-1315
15. Hooper L.V., Gordon J.I. Commensal host-bacterial relationships in the gut. Science. 292:2001;1115-1118
16. Hooper L.V., Wong M.H., Thelin A., Hansson L., Falk P.G., Gordon J.I. Molecular analysis of commensal host-microbial relationships in the intestine. Science. 291:2001;881-884
17. Freitas M., Axelsson L.G., Cayuela C., Midtvedt T., Trugnan G. Microbial-host interactions specifically control the glycosylation pattern in intestinal mouse mucosa. Histochem. Cell. Biol. 118:2002;149-161
18. Freitas M., Cayuela C., Antoine J.M., Piller F., Sapin C., Trugnan G. A heat labile soluble factor from Bacteroides thetaiotaomicron VPI-5482 specifically increases the galactosylation pattern of HT29-MTX cells. Cell. Microbiol. 3:2001;289-300
19. Wilson C.L., Ouellette A.J., Satchell D.P., Ayabe T., Lopez-Boado Y.S., Stratman J.L., Hultgren S.J., Matrisian L.M., Parks W.C. Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense. Science. 286:1999;113-117
20. Cebra J.J. Influences of microbiota on intestinal immune system development. Am. J. Clin. Nutr. 69:1999;1046S-1051S
21. Talham G.L., Jiang H.Q., Bos N.A., Cebra J.J. Segmented filamentous bacteria are potent stimuli of a physiologically normal state of the murine gut mucosal immune system. Infect. Immun. 67:1999;1992-2000
22. Kagnoff M.F., Eckmann L. Epithelial cells as sensors for microbial infection. J. Clin. Invest. 100:1997;6-10
23. Bevins C.L., Martin-Porter E., Ganz T. Defensins and innate host defence of the gastrointestinal tract. Gut. 45:1999;911-915
24. Ouellette A.J. Am. J. Physiol. 277:1999;G257-261
25. Corfield A.P., Myerscough N., Longman R., Sylvester P., Arul S., Pignatelli M. Mucins and mucosal protection in the gastrointestinal tract: new prospects for mucins in the pathology of gastrointestinal disease. Gut. 47:2000;589-594
26. Louvard D., Kedinger M., Hauri H.P. The differentiating intestinal epithelial cell: establishment and maintenance of functions through interactions between cellular structures. Annu. Rev. Cell. Biol. 8:1992;157-195
27. Kedinger M., Duluc I., Fritsch C., Lorentz O., Plateroti M., Freund J.N. Intestinal epithelial-mesenchymal cell interactions. Ann. N.Y. Acad. Sci. 859:1998;1-17
28. Montgomery R.K., Mulberg A.E., Grand R.J. Development of the human gastrointestinal tract: twenty years of progress. Gastroenterology. 116:1999;702-731
29. Anderson J.M., Balda M.S., Fanning A.S. The structure and regulation of tight junctions. Curr. Opin. Cell. Biol. 5:1993;772-778
30. Balda M.S., Matter K. Tight junctions. J. Cell. Sci. 111:1998;541-547
31. Cereijido M., Valdes J., Shoshani L., Contreras R.G. Role of tight junctions in establishing and maintaining cell polarity. Annu. Rev. Physiol. 60:1998;161-177
32. Citi S., Cordenonsi M. Tight junction proteins. Biochim. Biophys. Acta. 1448:1998;1-11
33. Madara J.L. Regulation of the movement of solutes across tight junctions. Annu. Rev. Physiol. 60:1998;143-159
34. Cossart P., Boquet P., Normark S., Rappuoli R. Cellular microbiology emerging. Science. 271:1996;315-316
35. Cossart P. Host/pathogen interactions. Subversion of the mammalian cell cytoskeleton by invasive bacteria. J. Clin. Invest. 99:1997;2307-2311
36. Finlay B.B., Cossart P. Exploitation of mammalian host cell functions by bacterial pathogens. Science. 276:1997;718-725
37. Finlay B.B., Falkow S. Common themes in microbial pathogenicity revisited. Microbiol. Mol. Biol. Rev. 61:1997;136-169
38. Laboisse C., Jarry A., Branka J.E., Merlin D., Bou-Hanna C., Vallette G. Regulation of mucin exocytosis from intestinal goblet cells. Biochem. Soc. Trans. 23:1995;810-813
39. Forstner G. Signal transduction, packaging and secretion of mucins. Annu. Rev. Physiol. 57:1995;585-605
40. Kraehenbuhl J.P., Neutra M.R. Epithelial M cells: differentiation and function. Annu. Rev. Cell Dev. Biol. 16:2000;301-332
41. Neutra M.R., Mantis N.J., Kraehenbuhl J.P. Collaboration of epithelial cells with organized mucosal lymphoid tissues Nat. Immunol. 2:2001;1004-1009
42. Didierlaurent A., Sirard J.C., Kraehenbuhl J.P., Neutra M.R. How the gut senses its content. Cell. Microbiol. 4:2002;61-72
43. Aderem A., Ulevitch R.J. Toll-like receptors in the induction of the innate immune response. Nature. 406:2000;782-787
44. Bals R. Epithelial antimicrobial peptides in host defense against infection. Respir. Res. 1:2000;141-150
45. Bals R. Antimicrobial peptides and peptide antibiotics. Med. Klin. 95:2000;496-502
46. Boman H.G. Innate immunity and the normal microflora. Immunol. Rev. 173:2000;5-16
47. Cunliffe R.N., Mahida Y.R. Antimicrobial peptides in innate intestinal host defence. Gut. 47:2000;16-17
48. Ganz T., Lehrer R.I. Antimicrobial peptides of vertebrates. Curr. Opin. Immunol. 10:1998;41-44
49. Ganz T. Antimicrobial proteins and peptides in host defense. Semin. Respir. Infect. 16:2001;4-10
50. Hiemstra P.S. Epithelial antimicrobial peptides and proteins: their role in host defence and inflammation. Paediatr. Respir. Rev. 2:2001;306-310
51. Huttner K.M., Bevins C.L. Antimicrobial peptides as mediators of epithelial host defense. Pediatr. Res. 45:1999;785-794
52. Lehrer R.I., Ganz T. Antimicrobial peptides in mammalian and insect host defence. Curr. Opin. Immunol. 11:1999;23-27
53. Mahida Y.R., Rose F., Chan W.C. Antimicrobial peptides in the gastrointestinal tract. Gut. 40:1997;161-163
54. Rao A.G. Antimicrobial peptides. Mol. Plant. Microbe Interact. 8:1995;6-13
55. Bevins C.L. Antimicrobial peptides as agents of mucosal immunity. Ciba Found. Symp. 186:1994;250-260
56. Ayabe T., Satchell D.P., Wilson C.L., Parks W.C., Selsted M.E., Ouellette A.J. Secretion of microbicidal alpha-defensins by intestinal Paneth cells in response to bacteria. Nat. Immunol. 1:2000;113-118
57. O'neil D.A., Porter E.M., Elewaut D., Anderson G.M., Eckmann L., Ganz T., Kagnoff M.F. Expression and regulation of the human beta-defensins hBD-1 and hBD-2 in intestinal epithelium. J. Immunol. 163:1999;6718-6724
58. Takahashi A., Wada A., Ogushi K., Maeda K., Kawahara T., Mawatari K., Kurazono H., Moss J., Hirayama T., Nakaya Y. Production of beta-defensin-2 by human colonic epithelial cells induced by Salmonella enteritidis flagella filament structural protein. FEBS Lett. 508:2001;484-488
59. Ogushi K., Wada A., Niidome T., Mori N., Oishi K., Nagatake T., Takahashi A., Asakura H., Makino S., Hojo H., Nakahara Y., Ohsaki M., Hatakeyama T., Aoyagi H., Kurazono H., Moss J., Hirayama T. Salmonella enteritidis FliC (flagella filament protein) induces human beta-defensin-2 mRNA production by Caco-2 cells. J. Biol. Chem. 276:2001;30521-30526
60. Salzman N.H., Chou M.M., De Jong H., Liu L., Porter E.M., Paterson Y. Enteric Salmonella infection inhibits Paneth cell antimicrobial peptide expression. Infect. Immun. 71:2003;1109-1115
61. Islam D., Bandholtz L., Nilsson J., Wigzell H., Christensson B., Agerberth B., Gudmundsson G. Downregulation of bactericidal peptides in enteric infections: a novel immune escape mechanism with bacterial DNA as a potential regulator. Nat. Med. 7:2001;180-185
62. Gunn J.S., Miller S.I. PhoP-PhoQ activates transcription of pmrAB, encoding a two-component regulatory system involved in Salmonella typhimurium antimicrobial peptide resistance. J. Bacteriol. 178:1996;6857-6864
63. Groisman E.A., Parra-Lopez C., Salcedo M., Lipps C.J., Heffron F. Resistance to host antimicrobial peptides is necessary for Salmonella virulence. Proc. Natl. Acad. Sci. USA. 89:1992;11939-11943
64. Miller S.I., Pulkkinen W.S., Selsted M.E., Mekalanos J.J. Characterization of defensin resistance phenotypes associated with mutations in the phoP virulence regulon of Salmonella typhimurium. Infect. Immun. 58:1990;3706-3710
65. Nicaise P., Gleizes A., Sandre C., Kergot R., Lebrec H., Forestier F., Labarre C. The intestinal microflora regulates cytokine production positively in spleen-derived macrophages but negatively in bone marrow-derived macrophages. Eur. Cytokine Netw. 10:1999;365-372
66. Hudault S., Guignot J., Servin A.L. Escherichia coli strains colonising the gastrointestinal tract protect germfree mice against Salmonella typhimurium infection. Gut. 49:2001;47-55
67. Riley M.A., Wertz J.E. Bacteriocin diversity: ecological and evolutionary perspectives. Biochimie. 84:2002;357-364
68. Ramare F., Nicoli J., Dabard J., Corring T., Ladire M., Gueugneau A.M., Raibaud P. Trypsin-dependent production of an antibacterial substance by a human Peptostreptococcus strain in gnotobiotic rats and in vitro. Appl. Environ. Microbiol. 59:1993;2876-2883
69. Dabard J., Bridonneau C., Phillipe C., Anglade P., Molle D., Nardi M., Ladire M., Girardin H., Marcille F., Gomez A., Fons M. Ruminococcin A, a new lantibiotic produced by a Ruminococcus gnavus strain isolated from human feces. Appl. Environ. Microbiol. 67:2001;4111-4118
70. Gomez A., Ladire M., Marcille F., Fons M. Trypsin mediates growth phase-dependent transcriptional regulation of genes involved in biosynthesis of ruminococcin A, a lantibiotic produced by a Ruminococcus gnavus strain from a human intestinal microbiota. J. Bacteriol. 184:2002;18-28
71. Mccartney A.L., Wenzhi W., Tannock G.W. Molecular analysis of the composition of the bifidobacterial and lactobacillus microflora of humans. Appl. Environ. Microbiol. 62:1996;4608-4613
72. Reuter G. The Lactobacillus and Bifidobacterium microflora of the human intestine: composition and succession. Curr. Issues Intest. Microbiol. 2:2001;43-53
73. Tannock G.W. The bifidobacterial and Lactobacillus microflora of humans. Clin. Rev. Allergy Immunol. 22:2002;231-253
74. Hopkins M.J., Sharp R., Macfarlane G.T. Variation in human intestinal microbiota with age. Dig. Liver Dis. 34(Suppl. 2):2002;S12-S18
75. Salminen S., Deighton M. Lactic acid bacteria in the gut in normal and disordered states. Dig. Dis. 10:1992;227-238
76. Salminen S., Bouley C., Boutron-Ruault M.C., Cummings J.H., Franck A., Gibson G.R., Isolauri E., Moreau M.C., Roberfroid M., Rowland I. Functional food science and gastrointestinal physiology and function. Br. J. Nutr. 80(Suppl. 1):1998;S147-S171
77. Kailasapathy K., Chin J. Survival and therapeutic potential of probiotic organisms with reference to Lactobacillus acidophilus and Bifidobacterium spp. Immunol. Cell Biol. 78:2000;80-88
78. Rolfe R.D. The role of probiotic cultures in the control of gastrointestinal health. J. Nutr. 130:2000;396S-402S
79. Saavedra J. Probiotics and infectious diarrhea. Am. J. Gastroenterol. 95:2000;S16-S18
80. Morelli L. In vitro selection of probiotic lactobacilli: a critical appraisal. Curr. Issues Intest. Microbiol. 1:2000;59-67
81. Alvarez-Olmos M.I., Oberhelman R.A. Probiotic agents and infectious diseases: a modern perspective on a traditional therapy. Clin. Infect. Dis. 32:2001;1567-1576
82. Elmer G.W. Probiotics: "living drugs" Am. J. Health-Syst. Ph. 58:2001;1101-1109
83. Elmer G.W., Mcfarland L.V. Biotherapeutic agents in the treatment of infectious diarrhea. Gastroenterol. Clin. North Am. 30:2001;837-854
84. Szajewska H., Mrukowicz J.Z. Probiotics in the treatment and prevention of acute infectious diarrhea in infants and children: a systematic review of published randomized, double-blind, placebo-controlled trials. J. Pediatr. Gastroenterol. Nutr. 33(Suppl. 2):2001;S17-S25
85. Isolauri E., Kirjavainen P.V., Salminen S. Probiotics: a role in the treatment of intestinal infection and inflammation? Gut. 50(Suppl. 3):2002;III54-III59
86. Ouwehand A.C., Salminen S., Isolauri E. Probiotics: an overview of beneficial effects. Antonie Van Leeuwenhoek. 82:2002;279-289
87. Sullivan A., Nord C.E. The place of probiotics in human intestinal infections. Int. J. Antimicrob. Agents. 20:2002;313-319
88. Sullivan A., Nord C.E. Probiotics in human infections. J. Antimicrob. Chemother. 50:2002;625-627
89. Canducci F., Cremonini F., Armuzzi A., Di Caro S., Gabrielli M., Santarelli L., Nista E., Lupascu A., De Martini D., Gasbarrini A. Probiotics and Helicobacter pylori eradication. Dig. Liver Dis. 34(Suppl. 2):2002;S81-83
90. Cremonini F., Di Caro S., Covino M., Armuzzi A., Gabrielli M., Santarelli L., Nista E.C., Cammarota G., Gasbarrini G., Gasbarrini A. Effect of different probiotic preparations on anti-Helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study. Am. J. Gastroenterol. 97:2002;2744-2749
91. Bruce A.W., Reid G. Intravaginal instillation of lactobacilli for prevention of recurrent urinary tract infections. Can. J. Microbiol. 34:1988;339-343
92. Reid G., Sobel J.D. Bacterial adherence in the pathogenesis of urinary tract infection: a review. Rev. Infect. Dis. 9:1987;470-487
93. Reid G., Bruce A.W., Mcgroarty J.A., Cheng K.J., Costerton J.W. Is there a role for lactobacilli in prevention of urogenital and intestinal infections? Clin. Microbiol. Rev. 3:1990;335-344
94. Reid G. The scientific basis for probiotic strains of Lactobacillus. Appl. Environ. Microbiol. 65:1999;3763-3766
95. Boris S., Barbes C. Role played by lactobacilli in controlling the population of vaginal pathogens. Microbes Infect. 2:2000;543-546
96. Reid G., Bruce A.W. Could probiotics be an option for treating and preventing urogenital infections? Medscape Womens Health. 6:2001;9
97. Reid G., Bruce A.W., Fraser N., Heinemann C., Owen J., Henning B. Oral probiotics can resolve urogenital infections. FEMS Immunol. Med. Microbiol. 30:2001;49-52
98. Reid G. The potential role of probiotics in pediatric urology. J. Urol. 168:2002;1512-1517
99. Cadieux P., Burton J., Gardiner G., Braunstein I., Bruce A.W., Kang C.Y., Reid G. Lactobacillus strains and vaginal ecology. JAMA. 287:2002;1940-1941
100. Chan R.C., Reid G., Irvin R.T., Bruce A.W., Costerton J.W. Competitive exclusion of uropathogens from human uroepithelial cells by Lactobacillus whole cells and cell wall fragments. Infect. Immun. 47:1985;84-89
101. Reid G., Chan R.C., Bruce A.W., Costerton J.W. Prevention of urinary tract infection in rats with an indigenous Lactobacillus casei strain. Infect. Immun. 49:1985;320-324
102. Reid G., Cook R.L., Bruce A.W. Examination of strains of lactobacilli for properties that may influence bacterial interference in the urinary tract. J. Urol. 138:1987;330-335
103. Zweibaum A., Laburthe M., Grasset E., Louvard D. Use of cultured cell lines in studies of intestinal cell differentiation and function. Handbook of Physiology. Schultz S.J.F.M., Frizell R.A. The Gastrointestinal System, Intestinal Absorption and Secretion. vol. IV:1991;223-255 American Physiological Society, Bethesda
104. Chauviere G., Coconnier M.H., Kerneis S., Fourniat J., Servin A.L. Adhesion of human Lactobacillus acidophilus strain LB to human enterocyte-like Caco-2 cells. J. Gen. Microbiol. 138:1992;1689-1696
105. Coconnier M.H., Klaenhammer T.R., Kerneis S., Bernet M.F., Servin A.L. Protein-mediated adhesion of Lactobacillus acidophilus BG2FO4 on human enterocyte and mucus-secreting cell lines in culture. Appl. Environ. Microbiol. 58:1992;2034-2039
106. Bernet M.F., Brassart D., Neeser J.R., Servin A.L. Lactobacillus acidophilus LA 1 binds to cultured human intestinal cell lines and inhibits cell attachment and cell invasion by enterovirulent bacteria. Gut. 35:1994;483-489
107. Hudault S., Lievin V., Bernet-Camard M.F., Servin A.L. Antagonistic activity exerted in vitro and in vivo by Lactobacillus casei (strain GG) against Salmonella typhimurium C5 infection. Appl. Environ. Microbiol. 63:1997;513-518
108. Tuomola E.M., Salminen S.J. Adhesion of some probiotic and dairy Lactobacillus strains to Caco-2 cell cultures. Int. J. Food Microbiol. 41:1998;45-51
109. Forestier C., De Champs C., Vatoux C., Joly B. Probiotic activities of Lactobacillus casei rhamnosus: in vitro adherence to intestinal cells and antimicrobial properties. Res. Microbiol. 152:2001;167-173
110. Gopal P.K., Prasad J., Smart J., Gill H.S. In vitro adherence properties of Lactobacillus rhamnosus DR20 and Bifidobacterium lactis DR10 strains and their antagonistic activity against an enterotoxigenic Escherichia coli. Int. J. Food Microbiol. 67:2001;207-216
111. De Champs C., Maroncle N., Balestrino D., Rich C., Forestier C. Persistence of colonization of intestinal mucosa by a probiotic strain, Lactobacillus casei subsp. rhamnosus Lcr35, after oral consumption. J. Clin. Microbiol. 41:2003;1270-1273
112. Coconnier M.H., Bernet M.F., Chauviere G., Servin A.L. Adhering heat-killed human Lactobacillus acidophilus, strain LB, inhibits the process of pathogenicity of diarrhoeagenic bacteria in cultured human intestinal cells. J. Diarrhoeal Dis. Res. 11:1993;235-242
113. Sanders M.E., Klaenhammer T.R. Invited review: the scientific basis of Lactobacillus acidophilus NCFM functionality as a probiotic. J. Dairy Sci. 84:2001;319-331
114. Bibiloni R., Perez P.F., Garrote G.L., Disalvo E.A., De Antoni G.L. Surface characterization and adhesive properties of bifidobacteria. Methods Enzymol. 336:2001;411-427
115. Bernet M.F., Brassart D., Neeser J.R., Servin A.L. Adhesion of human bifidobacterial strains to cultured human intestinal epithelial cells and inhibition of enteropathogen-cell interactions. Appl. Environ. Microbiol. 59:1993;4121-4128
116. He F., Ouwehan A.C., Hashimoto H., Isolauri E., Benno Y., Salminen S. Adhesion of Bifidobacterium spp. to human intestinal mucus. Microbiol. Immunol. 45:2001;259-262
117. He F., Ouwehand A.C., Isolauri E., Hashimoto H., Benno Y., Salminen S. Comparison of mucosal adhesion and species identification of bifidobacteria isolated from healthy and allergic infants. FEMS Immunol. Med. Microbiol. 30:2001;43-47
118. Del Re B., Sgorbati B., Miglioli M., Palenzona D. Adhesion, autoaggregation and hydrophobicity of 13 strains of Bifidobacterium longum. Lett. Appl. Microbiol. 31:2000;438-442
119. Ouwehand A.C., Isolauri E., Kirjavainen P.V., Salminen S.J. Adhesion of four Bifidobacterium strains to human intestinal mucus from subjects in different age groups. FEMS Microbiol. Lett. 172:1999;61-64
120. Ouwehand A.C., Isolauri E., Kirjavainen P.V., Tolkko S., Salminen S.J. The mucus binding of Bifidobacterium lactis Bb12 is enhanced in the presence of Lactobacillus GG and Lact. delbrueckii subsp. bulgaricus. Lett. Appl. Microbiol. 30:2000;10-13
121. Ouwehand A.C., Salminen S., Tolkko S., Roberts P., Ovaska J., Salminen E. Resected human colonic tissue: new model for characterizing adhesion of lactic acid bacteria. Clin. Diagn. Lab. Immunol. 9:2002;184-186
122. Juntunen M., Kirjavainen P.V., Ouwehand A.C., Salminen S.J., Isolauri E. Adherence of probiotic bacteria to human intestinal mucus in healthy infants and during rotavirus infection. Clin. Diagn. Lab. Immunol. 8:2001;293-296
123. Greene J.D., Klaenhammer T.R. Factors involved in adherence of lactobacilli to human Caco-2 cells. Appl. Environ. Microbiol. 60:1994;4487-4494
124. Blomberg L., Henriksson A., Conway P.L. Inhibition of adhesion of Escherichia coli K88 to piglet ileal mucus by Lactobacillus spp. Appl. Environ. Microbiol. 59:1993;34-39
125. Ouwehand A.C., Conway P.L. Purification and characterization of a component produced by Lactobacillus fermentum that inhibits the adhesion of K88 expressing Escherichia coli to porcine ileal mucus. J. Appl. Bacteriol. 80:1996;311-318
126. Rojas M., Conway P.L. Colonization by lactobacilli of piglet small intestinal mucus. J. Appl. Bacteriol. 81:1996;474-480
127. Rojas M., Ascencio F., Conway P.L. Purification and characterization of a surface protein from Lactobacillus fermentum 104R that binds to porcine small intestinal mucus and gastric mucin. Appl. Environ. Microbiol. 68:2002;2330-2336
128. Granato D., Perotti F., Masserey I., Rouvet M., Golliard M., Servin A., Brassart D. Cell surface-associated lipoteichoic acid acts as an adhesion factor for attachment of Lactobacillus johnsonii La1 to human enterocyte-like Caco-2 cells. Appl. Environ. Microbiol. 65:1999;1071-1077
129. Gusils C., Cuozzo S., Sesma F., Gonzalez S. Examination of adhesive determinants in three species of Lactobacillus isolated from chicken. Can. J. Microbiol. 48:2002;34-42
130. Fernandez M.F., Boris S., Barbes C. Probiotic properties of human lactobacilli strains to be used in the gastrointestinal tract. J. Appl. Microbiol. 94:2003;449-455
131. Ventura M., Jankovic I., Walker D.C., Pridmore R.D., Zink R. Identification and characterization of novel surface proteins in Lactobacillus johnsonii and Lactobacillus gasseri. Appl. Environ. Microbiol. 68:2002;6172-6181
132. Schell M.A., Karmirantzou M., Snel B., Vilanova D., Berger B., Pessi G., Zwahlen M.C., Desiere F., Bork P., Delley M., Pridmore R.D., Arigoni F. The genome sequence of Bifidobacterium longum reflects its adaptation to the human gastrointestinal tract. Proc. Natl. Acad. Sci. USA. 99:2002;14422-14427
133. Bernet-Camard M.F., Lievin V., Brassart D., Neeser J.R., Servin A.L., Hudault S. The human Lactobacillus acidophilus strain LA1 secretes a nonbacteriocin antibacterial substance(s) active in vitro and in vivo. Appl. Environ. Microbiol. 63:1997;2747-2753
134. Coconnier M.H., Bernet M.F., Kerneis S., Chauviere G., Fourniat J., Servin A.L. Inhibition of adhesion of enteroinvasive pathogens to human intestinal Caco-2 cells by Lactobacillus acidophilus strain LB decreases bacterial invasion. FEMS Microbiol. Lett. 110:1993;299-305
135. Hirano J., Yoshida T., Sugiyama T., Koide N., Mori I., Yokochi T. The effect of Lactobacillus rhamnosus on enterohemorrhagic Escherichia coli infection of human intestinal cells in vitro. Microbiol. Immunol. 47:2003;405-409
136. Lee Y.K., Puong K.Y. Competition for adhesion between probiotics and human gastrointestinal pathogens in the presence of carbohydrate. Br. J. Nutr. 88(Suppl. 1):2002;S101-S108
137. Jin L.Z., Ho Y.W., Ali M.A., Abdullah N., Jalaludin S. Effect of adherent Lactobacillus spp. on in vitro adherence of Salmonellae to the intestinal epithelial cells of chicken. J. Appl. Bacteriol. 81:1996;201-206
138. Spencer R.J., Chesson A. The effect of Lactobacillus spp. on the attachment of enterotoxigenic Escherichia coli to isolated porcine enterocytes. J. Appl. Bacteriol. 77:1994;215-220
139. Santos A., San Mauro M., Sanchez A., Torres J.M., Marquina D. The antimicrobial properties of different strains of Lactobacillus spp. isolated from kefir. Syst. Appl. Microbiol. 26:2003;434-437
140. Lee Y.J., Yu W.K., Heo T.R. Identification and screening for antimicrobial activity against Clostridium difficile of Bifidobacterium and Lactobacillus species isolated from healthy infant faeces. Int. J. Antimicrob. Agents. 21:2003;340-346
141. Tuomola E.M., Ouwehand A.C., Salminen S.J. The effect of probiotic bacteria on the adhesion of pathogens to human intestinal mucus. FEMS Immunol. Med. Microbiol. 26:1999;137-142
142. Matsumoto M., Tani H., Ono H., Ohishi H., Benno Y. Adhesive property of Bifidobacterium lactis LKM512 and predominant bacteria of intestinal microflora to human intestinal mucin. Curr. Microbiol. 44:2002;212-215
143. Mack D.R., Michail S., Wei S., Mcdougall L., Hollingsworth M.A. Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am. J. Physiol. 276:1999;G941-950
144. Lee Y.K., Puong K.Y., Ouwehand A.C., Salminen S. Displacement of bacterial pathogens from mucus and Caco-2 cell surface by lactobacilli. J. Med. Microbiol. 52:2003;925-930
145. Mattar A.F., Teitelbaum D.H., Drongowski R.A., Yongyi F., Harmon C.M., Coran A.G. Probiotics up-regulate MUC-2 mucin gene expression in a Caco-2 cell-culture model. Pediatr. Surg. Int. 18:2002;586-590
146. Lievin V., Peiffer I., Hudault S., Rochat F., Brassart D., Neeser J.R., Servin A.L. Bifidobacterium strains from resident infant human gastrointestinal microflora exert antimicrobial activity. Gut. 47:2000;646-652
147. Yamamoto K., Miwa T., Taniguchi H., Nagano T., Shimamura K., Tanaka T., Kumagai H. Binding specificity of Lactobacillus to glycolipids. Biochem. Biophys. Res. Commun. 228:1996;148-152
148. Neeser J.R., Granato D., Rouvet M., Servin A., Teneberg S., Karlsson K.A. Lactobacillus johnsonii La1 shares carbohydrate-binding specificities with several enteropathogenic bacteria. Glycobiology. 10:2000;1193-1199
149. Oro H.S., Kolsto A.B., Wenneras C., Svennerholm A.M. Identification of asialo GM1 as a binding structure for Escherichia coli colonization factor antigens. FEMS Microbiol. Lett. 60:1990;289-292
150. Fujiwara S., Hashiba H., Hirota T., Forstner J.F. Proteinaceous factor(s) in culture supernatant fluids of bifidobacteria which prevents the binding of enterotoxigenic Escherichia coli to gangliotetraosylceramide. Appl. Environ. Microbiol. 63:1997;506-512
151. Horie M., Ishiyama A., Fujihira-Ueki Y., Sillanpaa J., Korhonen T.K., Toba T. Inhibition of the adherence of Escherichia coli strains to basement membrane by Lactobacillus crispatus expressing an S-layer. J. Appl. Microbiol. 92:2002;396-403
152. Reid G., Burton J. Use of Lactobacillus to prevent infection by pathogenic bacteria. Microbes Infect. 4:2002;319-324
153. Hautefort I., Fléchon B., Degrouard J., Fons M. Adhesion to the digestive mucosa is not sufficient for durable persistence of different Lactobacillus fermentum strains in the digestive tract of mice. Microb. Ecol. Health Dis. 12:2000;48-56
154. Kabir A.M., Aiba Y., Takagi A., Kamiya S., Miwa T., Koga Y. Prevention of Helicobacter pylori infection by lactobacilli in a gnotobiotic murine model. Gut. 41:1997;49-55
155. Matsumoto S., Watanabe N., Imaoka A., Okabe Y. Preventive effects of Bifidobacterium- and Lactobacillus-fermented milk on the development of inflammatory bowel disease in senescence- accelerated mouse P1/Yit strain mice. Digestion. 64:2001;92-99
156. Bomba A., Nemcova R., Kastel R., Herich R., Pataky J., Cizek M. Interactions of Lactobacillus spp. and enteropathogenic Escherichia coli under in vitro and in vivo conditions. Vet. Med. 41:1996;155-158
157. Oozeer R., Goupil-Feuillerat N., Alpert C.A., Van De Guchte M., Anba J., Mengaud J., Corthier G. Lactobacillus casei is able to survive and initiate protein synthesis during its transit in the digestive tract of human flora-associated mice. Appl. Environ. Microbiol. 68:2002;3570-3574
158. Crociani J., Grill J.P., Huppert M., Ballongue J. Adhesion of different bifidobacteria strains to human enterocyte-like Caco-2 cells and comparison with in vivo study. Lett. Appl. Microbiol. 21:1995;146-148
159. Locascio M., Holgado A.P., Perdigon G., Oliver G. Enteric bifidobacteria: isolation from human infants and challenge studies in mice. Can. J. Microbiol. 47:2001;1048-1052
160. Frey A., Neutra M.R. Targeting of mucosal vaccines to Peyer's patch M cells. Behring Inst. Mitt. 1997;376-389
161. Wells J.M., Robinson K., Chamberlain L.M., Schofield K.M., Le Page R.W. Lactic acid bacteria as vaccine delivery vehicles. Antonie Van Leeuwenhoek. 70:1996;317-330
162. Pouwels P.H., Leer R.J., Shaw M., Heijne Den Bak-Glashouwer M.J., Tielen F.D., Smit E., Martinez B., Jore J., Conway P.L. Lactic acid bacteria as antigen delivery vehicles for oral immunization purposes. Int. J. Food Microbiol. 41:1998;155-167
163. Mercenier A., Muller-Alouf H., Grangette C. Lactic acid bacteria as live vaccines. Curr. Issues Mol. Biol. 2:2000;17-25
164. Vesa T., Pochart P., Marteau P. Pharmacokinetics of Lactobacillus plantarum NCIMB 8826, Lactobacillus fermentum KLD, and Lactococcus lactis MG 1363 in the human gastrointestinal tract. Aliment. Pharmacol. Ther. 14:2000;823-828
165. Seegers J.F. Lactobacilli as live vaccine delivery vectors: progress and prospects. Trends Biotechnol. 20:2002;508-515
166. Scheppler L., Vogel M., Zuercher A.W., Zuercher M., Germond J.E., Miescher S.M., Stadler B.M. Recombinant Lactobacillus johnsonii as a mucosal vaccine delivery vehicle. Vaccine. 20:2002;2913-2920
167. Plant L., Conway P. Association of Lactobacillus spp. with Peyer's patches in mice. Clin. Diagn. Lab. Immunol. 8:2001;320-324
168. Aiba Y., Suzuki N., Kabir A.M., Takagi A., Koga Y. Lactic acid-mediated suppression of Helicobacter pylori by the oral administration of Lactobacillus salivarius as a probiotic in a gnotobiotic murine model. Am. J. Gastroenterol. 93:1998;2097-2101
169. Coconnier M.H., Lievin V., Hemery E., Servin A.L. Antagonistic activity against Helicobacter infection in vitro and in vivo by the human Lactobacillus acidophilus strain LB. Appl. Environ. Microbiol. 64:1998;4573-4580
170. Filho-Lima J., Vieira E., Nicoli J. Antagonistic effect of Lactobacillus acidophilus, Saccharomyces boulardii, and Escherichia coli combinations against experimental infections with Shigella flexneri and Salmonella enteritidis subsp. typhimurium in gnotobiotic mice. J. Appl. Microbiol. 88:2000;365-370
171. Gill H.S., Shu Q., Lin H., Rutherfurd K.J., Cross M.L. Protection against translocating Salmonella typhimurium infection in mice by feeding the immuno-enhancing probiotic Lactobacillus rhamnosus strain HN001. Med. Microbiol. Immunol. 190:2001;97-104
172. Coconnier M.H., Lievin V., Bernet-Camard M.F., Hudault S., Servin A.L. Antibacterial effect of the adhering human Lactobacillus acidophilus strain LB. Antimicrob. Agents Chemother. 41:1997;1046-1052
173. Pascual M., Hugas M., Badiola J.I., Monfort J.M., Garriga M. Lactobacillus salivarius CTC2197 prevents Salmonella enteritidis colonization in chickens. Appl. Environ. Microbiol. 65:1999;4981-4986
174. Shu Q., Lin H., Rutherfurd K.J., Fenwick S.G., Prasad J., Gopal P.K., Gill H.S. Dietary Bifidobacterium lactis (HN019) enhances resistance to oral Salmonella typhimurium infection in mice. Microbiol. Immunol. 44:2000;213-222
175. Shu Q., Gill H.S. A dietary probiotic (Bifidobacterium lactis HN019) reduces the severity of Escherichia coli O157:H7 infection in mice. Med. Microbiol. Immunol. 189:2001;147-152
176. Asahara T., Nomoto K., Shimizu K., Watanuki M., Tanaka R. Increased resistance of mice to Salmonella enterica serovar Typhimurium infection by synbiotic administration of Bifidobacteria and transgalactosylated oligosaccharides. J. Appl. Microbiol. 91:2001;985-996
177. Suzuki T., Itoh K., Kaneko T., Suzuki H. Inhibition of bacterial translocation from the gastrointestinal tract of mice by oral administration of a culture condensate of Bifidobacterium longum. J. Vet. Med. Sci. 59:1997;665-669
178. Shu Q., Qu F., Gill H.S. Probiotic treatment using Bifidobacterium lactis HN019 reduces weanling diarrhea associated with rotavirus and Escherichia coli infection in a piglet model. J. Pediatr. Gastroenterol. Nutr. 33:2001;171-177
179. Mangell P., Nejdfors P., Wang M., Ahrne S., Westrom B., Thorlacius H., Jeppsson B. Lactobacillus plantarum 299v inhibits Escherichia coli-induced intestinal permeability. Dig. Dis. Sci. 47:2002;511-516
180. Ogawa M., Shimizu K., Nomoto K., Takahashi M., Watanuki M., Tanaka R., Tanaka T., Hamabata T., Yamasaki S., Takeda Y. Protective effect of Lactobacillus casei strain Shirota on Shiga toxin- producing Escherichia coli O157:H7 infection in infant rabbits. Infect. Immun. 69:2001;1101-1108
181. Bomba A., Nemcova R., Gancarcikova S., Herich R., Kastel R. Potentiation of the effectiveness of Lactobacillus casei in the prevention of E. coli induced diarrhea in conventional and gnotobiotic pigs. Adv. Exp. Med. Biol. 473:1999;185-190
182. Sato K. Enhancement of host resistance against Listeria infection by Lactobacillus casei: role of macrophages. Infect. Immun. 44:1984;445-451
183. De Waard R., Garssen J., Bokken G.C., Vos J.G. Antagonistic activity of Lactobacillus casei strain shirota against gastrointestinal Listeria monocytogenes infection in rats. Int. J. Food Microbiol. 73:2002;93-100
184. Yasui H., Kiyoshima J., Ushijima H. Passive protection against rotavirus-induced diarrhea of mouse pups born to and nursed by dams fed Bifidobacterium breve YIT4064. J. Infect. Dis. 172:1995;403-409
185. Thoreux K., Balas D., Bouley C., Senegas-Balas F. Diet supplemented with yoghurt or milk fermented by Lactobacillus casei DN-114 001 stimulates growth and brush-border enzyme activities in mouse small intestine. Digestion. 59:1998;349-359
186. Guerin-Danan C., Meslin J.C., Chambard A., Charpilienne A., Relano P., Bouley C., Cohen J., Andrieux C. Food supplementation with milk fermented by Lactobacillus casei DN-114 001 protects suckling rats from rotavirus-associated diarrhea. J. Nutr. 131:2001;111-117
187. Qiao H., Duffy L.C., Griffiths E., Dryja D., Leavens A., Rossman J., Rich G., Riepenhoff-Talty M., Locniskar M. Immune responses in rhesus rotavirus-challenged BALB/c mice treated with bifidobacteria and prebiotic supplements. Pediatr. Res. 51:2002;750-755
188. FAO/WHO (2001) Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria. Available from: http://www.fao.org/es/esn/food/ foodandfood_probio_en.stm
189. Borriello S.P., Hammes W.P., Holzapfel W., Marteau P., Schrezenmeir J., Vaara M., Valtonen V. Safety of probiotics that contain lactobacilli or bifidobacteria. Clin. Infect. Dis. 36:2003;775-780
190. Apostolou E., Kirjavainen P.V., Saxelin M., Rautelin H., Valtonen V., Salminen S.J., Ouwehand A.C. Good adhesion properties of probiotics: a potential risk for bacteremia? FEMS Immunol. Med. Microbiol. 31:2001;35-39
191. Asahara T., Takahashi M., Nomoto K., Takayama H., Onoue M., Morotomi M., Tanaka R., Yokokura T., Yamashita N. Assessment of safety of lactobacillus strains based on resistance to host innate defense mechanisms. Clin. Diagn. Lab. Immunol. 10:2003;169-173
192. Bezkorovainy A. Probiotics: determinants of survival and growth in the gut. Am. J. Clin. Nutr. 73:2001;399S-405S
193. Charteris W.P., Kelly P.M., Morelli L., Collins J.K. Development and application of an in vitro methodology to determine the transit tolerance of potentially probiotic Lactobacillus and Bifidobacterium species in the upper human gastrointestinal tract. J. Appl. Microbiol. 84:1998;759-768
194. Donnet-Hughes A., Rochat F., Serrant P., Aeschlimann J.M., Schiffrin E.J. Modulation of nonspecific mechanisms of defense by lactic acid bacteria: effective dose. J. Dairy Sci. 82:1999;863-869
195. Goldin B.R., Gorbach S.L., Saxelin M., Barakat S., Gualtieri L., Salminen S. Survival of Lactobacillus species (strain GG) in human gastrointestinal tract. Dig. Dis. Sci. 37:1992;121-128
196. Tannock G.W., Munro K., Harmsen H.J., Welling G.W., Smart J., Gopal P.K. Analysis of the fecal microflora of human subjects consuming a probiotic product containing Lactobacillus rhamnosus DR20. Appl. Environ. Microbiol. 66:2000;2578-2588
197. Isolauri E., Kaila M., Mykkanen H., Ling W.H., Salminen S. Oral bacteriotherapy for viral gastroenteritis. Dig. Dis. Sci. 39:1994;2595-2600
198. Sarem-Damerdji L., Sarem F., Marchal L., Nicolas J.P. In vitro colonization ability of human colon mucosa by exogenous Lactobacillus strains. FEMS Microbiol. Lett. 131:1995;133-137
199. Saxelin M., Pessi T., Salminen S. Fecal recovery following oral administration of Lactobacillus strain GG (ATCC 53103) in gelatine capsules to healthy volunteers. Int. J. Food Microbiol. 25:1995;199-203
200. Alander M., Korpela R., Saxelin M., Vilpponen-Salmela T., Mattila-Sandholm T., Von Wright A. Recovery of Lactobacillus rhamnosus GG from human colonic biopsies. Lett. Appl. Microbiol. 24:1997;361-364
201. Alander M., Satokari R., Korpela R., Saxelin M., Vilpponen-Salmela T., Mattila-Sandholm T., Von Wright A. Persistence of colonization of human colonic mucosa by a probiotic strain, Lactobacillus rhamnosus GG, after oral consumption. Appl. Environ. Microbiol. 65:1999;351-354
202. Agarwal R., Sharma N., Chaudhry R., Deorari A., Paul V.K., Gewolb I.H., Panigrahi P. Effects of oral Lactobacillus GG on enteric microflora in low-birth-weight neonates. J. Pediatr. Gastroenterol. Nutr. 36:2003;397-402
203. Cesena C., Morelli L., Alander M., Siljander T., Tuomola E., Salminen S., Mattila-Sandholm T., Vilpponen-Salmela T., Von Wright A. Lactobacillus crispatus and its nonaggregating mutant in human colonization trials. J. Dairy Sci. 84:2001;1001-1010
204. Guandalini S. The treatment of acute diarrhea in the third millennium: a pediatrician's perspective. Acta Gastro-enterol. Belg. 65:2002;33-36
205. Rosenfeldt V., Michaelsen K.F., Jakobsen M., Larsen C.N., Moller P.L., Tvede M., Weyrehter H., Valerius N.H., Paerregaard A. Effect of probiotic Lactobacillus strains on acute diarrhea in a cohort of nonhospitalized children attending day-care centers. Pediatr. Infect. Dis. J. 21:2002;417-419
206. Rosenfeldt V., Michaelsen K.F., Jakobsen M., Larsen C.N., Moller P.L., Pedersen P., Tvede M., Weyrehter H., Valerius N.H., Paerregaard A. Effect of probiotic Lactobacillus strains in young children hospitalized with acute diarrhea. Pediatr. Infect. Dis. J. 21:2002;411-416
207. Shornikova A.V., Casas I.A., Mykkanen H., Salo E., Vesikari T. Bacteriotherapy with Lactobacillus reuteri in rotavirus gastroenteritis. Pediatr. Infect. Dis. J. 16:1997;1103-1107
208. Shornikova A.V., Casas I.A., Isolauri E., Mykkanen H., Vesikari T. Lactobacillus reuteri as a therapeutic agent in acute diarrhea in young children. J. Pediatr. Gastroenterol. Nutr. 24:1997;399-404
209. Raza S., Graham S.M., Allen S.J., Sultana S., Cuevas L., Hart C.A., Kaila M., Isolauri E., Saxelin M., Arvilommi H., et al. Lactobacillus GG in acute diarrhea. Indian Pediatr. 32:1995;1140-1142
210. Guarino A., Canani R.B., Spagnuolo M.I., Albano F., Di Benedetto L. Oral bacterial therapy reduces the duration of symptoms and of viral excretion in children with mild diarrhea. J. Pediatr. Gastroenterol. Nutr. 25:1997;516-519
211. Shornikova A.V., Isolauri E., Burkanova L., Lukovnikova S., Vesikari T. A trial in the Karelian Republic of oral rehydration and Lactobacillus GG for treatment of acute diarrhoea. Acta Paediatr. 86:1997;460-465
212. Majamaa H., Isolauri E., Saxelin M., Vesikari T. Lactic acid bacteria in the treatment of acute rotavirus gastroenteritis. J. Pediatr. Gastroenterol. Nutr. 20:1995;333-338
213. Oberhelman R.A., Gilman R.H., Sheen P., Taylor D.N., Black R.E., Cabrera L., Lescano A.G., Meza R., Madico G. A placebo-controlled trial of Lactobacillus GG to prevent diarrhea in undernourished Peruvian children. J. Pediatr. 134:1999;15-20
214. Sherwood L., Gorbach S.L. Probiotics and gastrointestinal health. Am. J. Gastroenterol. 95:2000;S2-4
215. Simakachorn N., Pichaipat V., Rithipornpaisarn P., Kongkaew C., Tongpradit P., Varavithya W. Clinical evaluation of the addition of lyophilized, heat-killed Lactobacillus acidophilus LB to oral rehydration therapy in the treatment of acute diarrhea in children. J. Pediatr. Gastroenterol. Nutr. 30:2000;68-72
216. Guandalini S., Pensabene L., Zikri M.A., Dias J.A., Casali L.G., Hoekstra H., Kolacek S., Massar K., Micetic-Turk D., Papadopoulou A., De Sousa J.S., Sandhu B., Szajewska H., Weizman Z. Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European trial. J. Pediatr. Gastroenterol. Nutr. 30:2000;54-60
217. Van Niel C.W., Feudtner C., Garrison M.M., Christakis D.A. Lactobacillus therapy for acute infectious diarrhea in children: a meta-analysis. Pediatrics. 109:2002;678-684
218. Hilton E., Kolakowski P., Singer C., Smith M. Efficacy of Lactobacillus GG as a diarrheal reventive in travelers. J. Travel Med. 4:1997;41-43
219. Dupont H.L. Lactobacillus GG in prevention of traveler's diarrhea: an encouraging first step. J. Travel Med. 4:1997;1-2
220. Dupont H.L. Prevention of diarrhea by the probiotic, Lactobacillus GG. J. Pediatr. 134:1999;1-2
221. Oksanen P.J., Salminen S., Saxelin M., Hamalainen P., Ihantola-Vormisto A., Muurasniemi-Isoviita L., Nikkari S., Oksanen T., Porsti I., Salminen E., et al. Prevention of travellers' diarrhoea by Lactobacillus GG. Ann. Med. 22:1990;53-56
222. Sullivan A., Edlund C., Nord C.E. Effect of antimicrobial agents on the ecological balance of human microflora. Lancet Infect. Dis. 1:2001;101-114
223. Szajewska H., Kotowska M., Mrukowicz J.Z., Armanska M., Mikolajczyk W. Efficacy of Lactobacillus GG in prevention of nosocomial diarrhea in infants. J. Pediatr. 138:2001;361-365
224. Pedone C.A., Bernabeu A.O., Postaire E.R., Bouley C.F., Reinert P. The effect of supplementation with milk fermented by Lactobacillus casei (strain DN-114 001) on acute diarrhoea in children attending day care centres. Int. J. Clin. Pract. 53:1999;179-184
225. Pedone C.A., Arnaud C.C., Postaire E.R., Bouley C.F., Reinert P. Multicentric study of the effect of milk fermented by Lactobacillus casei on the incidence of diarrhoea. Int. J. Clin. Pract. 54:2000;568-571
226. Siitonen S., Vapaatalo H., Salminen S., Gordin A., Saxelin M., Wikberg R., Kirkkola A.L. Effect of Lactobacillus GG yoghurt in prevention of antibiotic associated diarrhoea. Ann. Med. 22:1990;57-59
227. Arvola T., Laiho K., Torkkeli S., Mykkanen H., Salminen S., Maunula L., Isolauri E. Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: a randomized study. Pediatrics. 104:1999;e64
228. Vanderhoof J.A., Whitney D.B., Antonson D.L., Hanner T.L., Lupo J.V., Young R.J. Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children. J. Pediatr. 135:1999;564-568
229. Pochapin M. The effect of probiotics on Clostridium difficile diarrhea. Am. J. Gastroenterol. 95:2000;S11-13
230. Thomas M.R., Litin S.C., Osmon D.R., Corr A.P., Weaver A.L., Lohse C.M. Lack of effect of Lactobacillus GG on antibiotic-associated diarrhea: a randomized, placebo-controlled trial. Mayo Clin. Proc. 76:2001;883-889
231. Cremonini F., Di Caro S., Nista E.C., Bartolozzi F., Capelli G., Gasbarrini G., Gasbarrini A. Meta-analysis: the effect of probiotic administration on antibiotic-associated diarrhoea. Aliment. Pharmacol. Ther. 16:2002;1461-1467
232. Cremonini F., Di Caro S., Santarelli L., Gabrielli M., Candelli M., Nista E.C., Lupascu A., Gasbarrini G., Gasbarrini A. Probiotics in antibiotic-associated diarrhoea. Dig. Liver Dis. 34(Suppl. 2):2002;S78-S80
233. Hamilton-Miller J.M. The role of probiotics in the treatment and prevention of Helicobacter pylori infection. Int. J. Antimicrob. Agents. 22:2003;360-366
234. Mrda Z., Zivanovic M., Rasic J., Gajin S., Somer L., Trbojevic S., Majoros J., Petrovic Z. Therapy of Helicobacter pylori infection using Lactobacillus acidophilus. Med. Pregl. 51:1998;343-345
235. Shimizu T., Haruna H., Hisada K., Yamashiro Y. Effects of Lactobacillus gasseri OLL 2716 (LG21) on Helicobacter pylori infection in children. J. Antimicrob. Chemother. 50:2002;617-618
236. Michetti P., Dorta G., Wiesel P.H., Brassart D., Verdu E., Herranz M., Felley C., Porta N., Rouvet M., Blum A.L., Corthesy-Theulaz I. Effect of whey-based culture supernatant of Lactobacillus acidophilus (johnsonii) La1 on Helicobacter pylori infection in humans. Digestion. 60:1999;203-209
237. Felley C.P., Corthesy-Theulaz I., Rivero J.L., Sipponen P., Kaufmann M., Bauerfeind P., Wiesel P.H., Brassart D., Pfeifer A., Blum A.L., Michetti P. Favourable effect of an acidified milk (LC-1) on Helicobacter pylori gastritis in man. Eur. J. Gastroenterol. Hepatol. 13:2001;25-29
238. Gotteland M., Cruchet S. Suppressive effect of frequent ingestion of Lactobacillus johnsonii La1 on Helicobacter pylori colonization in asymptomatic volunteers. J. Antimicrob. Chemother. 51:2003;1317-1319
239. Cruchet S., Obregon M.C., Salazar G., Diaz E., Gotteland M. Effect of the ingestion of a dietary product containing Lactobacillus johnsonii La1 on Helicobacter pylori colonization in children. Nutrition. 19:2003;716-721
240. Sakamoto I., Igarashi M., Kimura K., Takagi A., Miwa T., Koga Y. Suppressive effect of Lactobacillus gasseri OLL 2716 (LG21) on Helicobacter pylori infection in humans. J. Antimicrob. Chemother. 47:2001;709-710
241. Ushiyama A., Tanaka K., Aiba Y., Shiba T., Takagi A., Mine T., Koga Y. Lactobacillus gasseri OLL2716 as a probiotic in clarithromycin-resistant Helicobacter pylori infection. J. Gastroenterol. Hepatol. 18:2003;986-991
242. Cats A., Kuipers E.J., Bosschaert M.A., Pot R.G., Vandenbroucke-Grauls C.M., Kusters J.G. Effect of frequent consumption of a Lactobacillus casei-containing milk drink in Helicobacter pylori-colonized subjects. Aliment. Pharmacol. Ther. 17:2003;429-435
243. Canducci F., Armuzzi A., Cremonini F., Cammarota G., Bartolozzi F., Pola P., Gasbarrini G., Gasbarrini A. A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates. Aliment. Pharmacol. Ther. 14:2000;1625-1629
244. Wendakoon C.N., Thomson A.B., Ozimek L. Lack of therapeutic effect of a specially designed yogurt for the eradication of Helicobacter pylori infection. Digestion. 65:2002;16-20
245. Asahara T., Nomoto K., Watanuki M., Yokokura T. Antimicrobial activity of intraurethrally administered probiotic Lactobacillus casei in a murine model of Escherichia coli urinary tract infection. Antimicrob. Agents Chemother. 45:2001;1751-1760
246. Silva De Ruiz C., Lopez De Bocanera M.E., Nader De Macias M.E., Pesce De Ruiz Holgado A.A. Effect of lactobacilli and antibiotics on E. coli urinary infections in mice. Biol. Pharm. Bull. 19:1996;88-93
247. Barbes C., Boris S. Potential role of lactobacilli as prophylactic agents against genital pathogens. AIDS Patient Care STDS. 13:1999;747-751
248. Reid G., Beuerman D., Heinemann C., Bruce A.W. Probiotic Lactobacillus dose required to restore and maintain a normal vaginal flora. FEMS Immunol. Med. Microbiol. 32:2001;37-41
249. Gardiner G.E., Heinemann C., Bruce A.W., Beuerman D., Reid G. Persistence of Lactobacillus fermentum RC-14 and Lactobacillus rhamnosus GR-1 but not L. rhamnosus GG in the human vagina as demonstrated by randomly amplified polymorphic DNA. Clin. Diagn. Lab. Immunol. 9:2002;92-96
250. Burton J.P., Cadieux P.A., Reid G. Improved understanding of the bacterial vaginal microbiota of women before and after probiotic instillation. Appl. Environ. Microbiol. 69:2003;97-101
251. Reid G., Charbonneau D., Erb J., Kochanowski B., Beuerman D., Poehner R., Bruce A.W. Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women. FEMS Immunol. Med. Microbiol. 35:2003;131-134
252. Eschenbach D.A., Davick P.R., Williams B.L., Klebanoff S.J., Young-Smith K., Critchlow C.M., Holmes K.K. Prevalence of hydrogen peroxide-producing Lactobacillus species in normal women and women with bacterial vaginosis. J. Clin. Microbiol. 27:1989;251-256
253. 2-generating lactobacilli. J. Infect. Dis. 164:1991;94-100
254. Hillier S.L., Krohn M.A., Klebanoff S.J., Eschenbach D.A. The relationship of hydrogen peroxide-producing lactobacilli to bacterial vaginosis and genital microflora in pregnant women. Obstet. Gynecol. 79:1992;369-373
255. 2-producing lactobacilli, and bacterial vaginosis in pregnant women. Clin. Infect. Dis. 16(Suppl. 4):1993;S273-S281
256. St Amant D.C., Valentin-Bon I.E., Jerse A.E. Inhibition of Neisseria gonorrhoeae by Lactobacillus species that are commonly isolated from the female genital tract. Infect. Immun. 70:2002;7169-7171
257. Aroutcheva A., Gariti D., Simon M., Shott S., Faro J., Simoes J.A., Gurguis A., Faro S. Defense factors of vaginal lactobacilli. Am. J. Obstet. Gynecol. 185:2001;375-379
258. Mastromarino P., Brigidi P., Macchia S., Maggi L., Pirovano F., Trinchieri V., Conte U., Matteuzzi D. Characterization and selection of vaginal Lactobacillus strains for the preparation of vaginal tablets. J. Appl. Microbiol. 93:2002;884-893
259. 2-generating Lactobacillus species for probiotic use. Curr. Microbiol. 38:1999;279-284
260. 2-producing Lactobacillus paracasei subsp. paracasei isolated from the human vagina. FEMS Immunol. Med. Microbiol. 23:1999;87-92
261. Van De Guchte M., Ehrlich S.D., Maguin E. Production of growth-inhibiting factors by Lactobacillus delbrueckii. J. Appl. Microbiol. 91:2001;147-153
262. Vandenbergh P.A. Lactic acid bacteria, their metabolic products and interference with microbial growth. FEMS Microbiol. Rev. 12:1993;221-238
263. Lehto E.M., Salminen S.J. Inhibition of Salmonella typhimurium adhesion to Caco-2 cell cultures by Lactobacillus strain GG spent culture supernate: only a pH effect? FEMS. Immunol. Med. Microbiol. 18:1997;125-132
264. Apella M.C., Gonzalez S.N., Nader De Macias M.E., Romero N., Oliver G. In vitro studies on the growth of Shigella sonnei by Lactobacillus casei and Lact. acidophilus. J. Appl. Bacteriol. 73:1992;480-483
265. Brashears M.M., Reilly S.S., Gilliland S.E. Antagonistic action of cells of Lactobacillus lactis toward Escherichia coli 0157:H7 on refrigerated raw chicken meat. J. Food Prot. 61:1998;166-170
266. Ogawa M., Shimizu K., Nomoto K., Tanaka R., Hamabata T., Yamasaki S., Takeda T., Takeda Y. Inhibition of in vitro growth of Shiga toxin-producing Escherichia coli O157:H7 by probiotic Lactobacillus strains due to production of lactic acid. Int. J. Food Microbiol. 68:2001;135-140
267. Strus M., Pakosz K., Gosciniak H., Przondo-Mordarska A., Rozynek E., Pituch H., Meisel-Mikolajczyk F., Heczko P.B. Antagonistic activity of Lactobacillus bacteria strains against anaerobic gastrointestinal tract pathogens ( Helicobacter pylori, Campylobacter coli, Campylobacter jejuni, Clostridium difficile). Med. Dosw. Mikrobiol. 53:2001;133-142
268. Bhatia S.J., Kochar N., Abraham P., Nair N.G., Mehta A.P. Lactobacillus acidophilus inhibits growth of Campylobacter pylori in vitro. J. Clin. Microbiol. 27:1989;2328-2330
269. Midolo P.D., Lambert J.R., Hull R., Luo F., Grayson M.L. In vitro inhibition of Helicobacter pylori NCTC 11637 by organic acids and lactic acid bacteria. J. Appl. Bacteriol. 79:1995;475-479
270. Jin L.Z., Ho Y.W., Abdullah N., Ali M.A., Jalaludin S. Antagonistic effects of intestinal Lactobacillus isolates on pathogens of chicken. Lett. Appl. Microbiol. 23:1996;67-71
271. Niku-Paavola M.L., Laitila A., Mattila-Sandholm T., Haikara A. New types of antimicrobial compounds produced by Lactobacillus plantarum. J. Appl. Microbiol. 86:1999;29-35
272. Alakomi H.L., Skytta E., Saarela M., Mattila-Sandholm T., Latva-Kala K., Helander I.M. Lactic acid permeabilizes gram-negative bacteria by disrupting the outer membrane. Appl. Environ. Microbiol. 66:2000;2001-2005
273. Gan B.S., Kim J., Reid G., Cadieux P., Howard J.C. Lactobacillus fermentum RC-14 inhibits Staphylococcus aureus infection of surgical implants in rats. J. Infect. Dis. 185:2002;1369-1372
274. Reid G., Lam D., Bruce A.W., Van Der Mei H.C., Busscher H.J. Adhesion of lactobacilli to urinary catheters and diapers: effect of surface properties. J. Biomed. Mater. Res. 28:1994;731-734
275. Reid G. Adhesion of urogenital organisms to polymers and prosthetic devices. Methods Enzymol. 253:1995;514-519
276. Velraeds M.M., Van Der Mei H.C., Reid G., Busscher H.J. Inhibition of initial adhesion of uropathogenic Enterococcus faecalis by biosurfactants from Lactobacillus isolates. Appl. Environ. Microbiol. 62:1996;1958-1963
277. Shanahan F. Intestinal lymphoepithelial communication. Adv. Exp. Med. Biol. 473:1999;1-9
278. Delneste Y., Donnet-Hughes A., Schiffrin E.J. Functional foods: mechanisms of action on immunocompetent cells. Nutr. Rev. 56:1998;S93-98
279. Perdigon G., Fuller R., Raya R. Lactic acid bacteria and their effect on the immune system. Curr. Issues Intest. Microbiol. 2:2001;27-42
280. Gershwin M.E., Schiffrin E. Probiotics and immunity. Introduction. Clin. Rev. Allergy Immunol. 22:2002;205-206
281. Schiffrin E.J., Blum S. Interactions between the microbiota and the intestinal mucosa. Eur. J. Clin. Nutr. 56(Suppl. 3):2002;S60-S64
282. Blum S., Schiffrin E.J. Intestinal microflora and homeostasis of the mucosal immune response: implications for probiotic bacteria? Curr. Issues Intest. Microbiol. 4:2003;53-60
283. Klebanoff S.J., Watts D.H., Mehlin C., Headley C.M. Lactobacilli and vaginal host defense: activation of the human immunodeficiency virus type 1 long terminal repeat, cytokine production, and NF-kappaB. J. Infect. Dis. 179:1999;653-660
284. Chen T., Isomaki P., Rimpilainen M., Toivanen P. Human cytokine responses induced by gram-positive cell walls of normal intestinal microbiota. Clin. Exp. Immunol. 118:1999;261-267
285. Miettinen M., Vuopio-Varkila J., Varkila K. Production of human tumor necrosis factor alpha, interleukin-6, and interleukin-10 is induced by lactic acid bacteria. Infect. Immun. 64:1996;5403-5405
286. Rangavajhyala N., Shahani K.M., Sridevi G., Srikumaran S. Nonlipopolysaccharide component(s) of Lactobacillus acidophilus stimulate(s) the production of interleukin-1 alpha and tumor necrosis factor-alpha by murine macrophages. Nutr. Cancer. 28:1997;130-134
287. Matar C., Valdez J.C., Medina M., Rachid M., Perdigon G. Immunomodulating effects of milks fermented by Lactobacillus helveticus and its non-proteolytic variant. J. Dairy Res. 68:2001;601-609
288. Leblanc J.G., Matar C., Valdez J.C., Leblanc J., Perdigon G. Immunomodulating effects of peptidic fractions issued from milk fermented with Lactobacillus helveticus. J. Dairy Sci. 85:2002;2733-2742
289. Morita H., He F., Fuse T., Ouwehand A.C., Hashimoto H., Hosoda M., Mizumachi K., Kurisaki J. Cytokine production by the murine macrophage cell line J774.1 after exposure to lactobacilli. Biosci. Biotechnol. Biochem. 66:2002;1963-1966
290. Hessle C., Hanson L.A., Wold A.E. Lactobacilli from human gastrointestinal mucosa are strong stimulators of IL-12 production. Clin. Exp. Immunol. 116:1999;276-282
291. Kato I., Tanaka K., Yokokura T. Lactic acid bacterium potently induces the production of interleukin-12 and interferon-gamma by mouse splenocytes. Int. J Immunopharmacol. 21:1999;121-131
292. Tejada-Simon M.V., Ustunol Z., Pestka J.J. Ex vivo effects of lactobacilli, streptococci, and bifidobacteria ingestion on cytokine and nitric oxide production in a murine model. J. Food Protect. 62:1999;162-169
293. Tejada-Simon M.V., Pestka J.J. Proinflammatory cytokine and nitric oxide induction in murine macrophages by cell wall and cytoplasmic extracts of lactic acid bacteria. J. Food Protect. 62:1999;1435-1444
294. Tejada-Simon M.V., Ustunol Z., Pestka J.J. Effects of lactic acid bacteria ingestion of basal cytokine mRNA and immunoglobulin levels in the mouse. J. Food Protect. 62:1999;287-291
295. Korhonen R., Korpela R., Saxelin M., Maki M., Kankaanranta H., Moilanen E. Induction of nitric oxide synthesis by probiotic Lactobacillus rhamnosus GG in J774 macrophages and human T84 intestinal epithelial cells. Inflammation. 25:2001;223-232
296. He F., Morita H., Ouwehand A.C., Hosoda M., Hiramatsu M., Kurisaki J., Isolauri E., Benno Y., Salminen S. Stimulation of the secretion of pro-inflammatory cytokines by Bifidobacterium strains. Microbiol. Immunol. 46:2002;781-785
297. Coconnier M.H., Lievin V., Lorrot M., Servin A.L. Antagonistic activity of Lactobacillus acidophilus LB against intracellular Salmonella enterica serovar Typhimurium infecting human enterocyte-like Caco-2/TC-7 Cells. Appl. Environ. Microbiol. 66:2000;1152-1157
298. Lammers K.M., Helwig U., Swennen E., Rizzello F., Venturi A., Caramelli E., Kamm M.A., Brigidi P., Gionchetti P., Campieri M. Effect of probiotic strains on interleukin 8 production by HT29/19A cells. Am. J. Gastroenterol. 97:2002;1182-1186
299. Morita H., He F., Fuse T., Ouwehand A.C., Hashimoto H., Hosoda M., Mizumachi K., Kurisaki J. Adhesion of lactic acid bacteria to Caco-2 cells and their effect on cytokine secretion. Microbiol. Immunol. 46:2002;293-297
300. Wallace T.D., Bradley S., Buckley N.D., Green-Johnson J.M. Interactions of lactic acid bacteria with human intestinal epithelial cells: effects on cytokine production. J. Food Protect. 66:2003;466-472
301. Mccracken V.J., Chun T., Baldeon M.E., Ahrne S., Molin G., Mackie R.I., Gaskins H.R. TNF-alpha sensitizes HT-29 colonic epithelial cells to intestinal lactobacilli. Exp. Biol. Med. 227:2002;665-670
302. Haller D., Bode C., Hammes W.P., Pfeifer A.M., Schiffrin E.J., Blum S. Non-pathogenic bacteria elicit a differential cytokine response by intestinal epithelial cell/leucocyte co-cultures. Gut. 47:2000;79-87
303. Borruel N., Casellas F., Antolin M., Llopis M., Carol M., Espiin E., Naval J., Guarner F., Malagelada J.R. Effects of nonpathogenic bacteria on cytokine secretion by human intestinal mucosa. Am. J. Gastroenterol. 98:2003;865-870
304. Christensen H.R., Frokiaer H., Pestka J.J. Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J. Immunol. 168:2002;171-178
305. Vidal K., Donnet-Hughes A., Granato D. Lipoteichoic acids from Lactobacillus johnsonii strain La1 and Lactobacillus acidophilus strain La10 antagonize the responsiveness of human intestinal epithelial HT29 cells to lipopolysaccharide and gram- negative bacteria. Infect. Immun. 70:2002;2057-2064
306. Haller D., Serrant P., Granato D., Schiffrin E.J., Blum S. Activation of human NK cells by staphylococci and lactobacilli requires cell contact-dependent costimulation by autologous monocytes. Clin. Diagn. Lab. Immunol. 9:2002;649-657
307. Ibnou-Zekri N., Blum S., Schiffrin E.J., Von Der Weid T. Divergent patterns of colonization and immune response elicited from two intestinal Lactobacillus strains that display similar properties in vitro. Infect. Immun. 71:2003;428-436
308. Zalashko M.V., Anisimova H.I., Bortkevich L.G. Antimicrobial and immunomodulatory activities of Lactobacillus acidophilus Ke-10. Prikl. Biokhim. Mikrobiol. 33:1997;305-309
309. Link-Amster H., Rochat F., Saudan K.Y., Mignot O., Aeschlimann J.M. Modulation of a specific humoral immune response and changes in intestinal flora mediated through fermented milk intake. FEMS Immunol. Med. Microbiol. 10:1994;55-63
310. Schiffrin E.J., Rochat F., Link-Amster H., Aeschlimann J.M., Donnet-Hughes A. Immunomodulation of human blood cells following the ingestion of lactic acid bacteria. J. Dairy Sci. 78:1995;491-497
311. Schiffrin E.J., Brassart D., Servin A.L., Rochat F., Donnet-Hughes A. Immune modulation of blood leukocytes in humans by lactic acid bacteria: criteria for strain selection. Am. J. Clin. Nutr. 66:1997;515S-520S
312. Yasui H., Shida K., Matsuzaki T., Yokokura T. Immunomodulatory function of lactic acid bacteria. Antonie Van Leeuwenhoek. 76:1999;383-389
313. Matsuzaki T. Immunomodulation by treatment with Lactobacillus casei strain Shirota. Int. J. Food Microbiol. 41:1998;133-140
314. Matsuzaki T., Chin J. Modulating immune responses with probiotic bacteria. Immunol. Cell Biol. 78:2000;67-73
315. Hori T., Kiyoshima J., Yasui H. Effect of an oral administration of Lactobacillus casei strain Shirota on the natural killer activity of blood mononuclear cells in aged mice. Biosci. Biotechnol. Biochem. 67:2003;420-422
316. Yan F., Polk D.B. Probiotic bacterium prevents cytokine-induced apoptosis in intestinal epithelial cells. J. Biol. Chem. 277:2002;50959-50965
317. Pena J.A., Versalovic J. Lactobacillus rhamnosus GG decreases TNF-alpha production in lipopolysaccharide-activated murine macrophages by a contact-independent mechanism. Cell. Microbiol. 5:2003;277-285
318. Veckman V., Miettinen M., Matikainen S., Lande R., Giacomini E., Coccia E.M., Julkunen I. Lactobacilli and streptococci induce inflammatory chemokine production in human macrophages that stimulates Th1 cell chemotaxis. J. Leukoc. Biol. 74:2003;395-402
319. Kirjavainen P.V., Elnezami H.S., Salminen S.J., Ahokas J.T., Wright P.F. Effects of orally administered viable Lactobacillus rhamnosus GG and Propionibacterium freudenreichii subsp. shermanii JS on mouse lymphocyte proliferation. Clin. Diagn. Lab. Immunol. 6:1999;799-802
320. Fang H., Elina T., Heikki A., Seppo S. Modulation of humoral immune response through probiotic intake. FEMS Immunol. Med. Microbiol. 29:2000;47-52
321. Isolauri E., Joensuu J., Suomalainen H., Luomala M., Vesikari T. Improved immunogenicity of oral D x RRV reassortant rotavirus vaccine by Lactobacillus casei GG. Vaccine. 13:1995;310-312
322. Schultz M., Linde H.J., Lehn N., Zimmermann K., Grossmann J., Falk W., Scholmerich J. Immunomodulatory consequences of oral administration of Lactobacillus rhamnosus strain GG in healthy volunteers. J. Dairy Res. 70:2003;165-173
323. Gill H.S., Rutherfurd K.J., Prasad J., Gopal P.K. Enhancement of natural and acquired immunity by Lactobacillus rhamnosus (HN001), Lactobacillus acidophilus (HN017) and Bifidobacterium lactis (HN019). Br. J. Nutr. 83:2000;167-176
324. Kirjavainen P.V., El-Nezami H.S., Salminen S.J., Ahokas J.T., Wright P.F. The effect of orally administered viable probiotic and dairy lactobacilli on mouse lymphocyte proliferation. FEMS Immunol. Med. Microbiol. 26:1999;131-135
325. Perdigon G., Alvarez S., Rachid M., Aguero G., Gobbato N. Immune system stimulation by probiotics. J. Dairy Sci. 78:1995;1597-1606
326. Perdigon G., Maldonado Galdeano C., Valdez J.C., Medici M. Interaction of lactic acid bacteria with the gut immune system. Eur. J. Clin. Nutr. 56(Suppl. 4):2002;S21-S26
327. Perdigon G., Vintini E., Alvarez S., Medina M., Medici M. Study of the possible mechanisms involved in the mucosal immune system activation by lactic acid bacteria. J. Dairy Sci. 82:1999;1108-1114
328. Sheih Y.H., Chiang B.L., Wang L.H., Liao C.K., Gill H.S. Systemic immunity-enhancing effects in healthy subjects following dietary consumption of the lactic acid bacterium Lactobacillus rhamnosus HN001. J. Am. Coll. Nutr. 20:2001;149-156
329. Gill H.S., Rutherfurd K.J., Cross M.L., Gopal P.K. Enhancement of immunity in the elderly by dietary supplementation with the probiotic Bifidobacterium lactis HN019. Am. J. Clin. Nutr. 74:2001;833-839
330. Gill H.S., Cross M.L., Rutherfurd K.J., Gopal P.K. Dietary probiotic supplementation to enhance cellular immunity in the elderly. Br. J. Biomed. Sci. 58:2001;94-96
331. Klaenhammer T.R. Genetics of bacteriocins produced by lactic acid bacteria. FEMS Microbiol. Rev. 12:1993;39-85
332. Jack R.W., Tagg J.R., Ray B. Bacteriocins of gram-positive bacteria. Microbiol. Rev. 59:1995;171-200
333. Mcauliffe O., Ross R.P., Hill C. Lantibiotics: structure, biosynthesis and mode of action. FEMS Microbiol. Rev. 25:2001;285-308
334. Ennahar S., Sashihara T., Sonomoto K., Ishizaki A. Class IIa bacteriocins: biosynthesis, structure and activity. FEMS Microbiol. Rev. 24:2000;85-106
335. Nes I.F., Holo H. Class II antimicrobial peptides from lactic acid bacteria. Biopolymers. 55:2000;50-61
336. Sablon E., Contreras B., Vandamme E. Antimicrobial peptides of lactic acid bacteria: mode of action, genetics and biosynthesis. Adv. Biochem. Eng. Biotechnol. 68:2000;21-60
337. Kim T.S., Hur J.W., Yu M.A., Cheigh C.I., Kim K.N., Hwang J.K., Pyun Y.R. Antagonism of Helicobacter pylori by bacteriocins of lactic acid bacteria. J. Food Protect. 66:2003;3-12
338. Stevens K.A., Sheldon B.W., Klapes N.A., Klaenhammer T.R. Nisin treatment for inactivation of Salmonella species and other gram-negative bacteria. Appl. Environ. Microbiol. 57:1991;3613-3615
339. Zamfir M., Callewaert R., Cornea P.C., Savu L., Vatafu I., De Vuyst L. Purification and characterization of a bacteriocin produced by Lactobacillus acidophilus IBB 801. J Appl Microbiol. 87:1999;923-931
340. Zamfir M., Callewaert R., Cornea P.C., De Vuyst L. Production kinetics of acidophilin 801, a bacteriocin produced by Lactobacillus acidophilus IBB 801. FEMS Microbiol. Lett. 190:2000;305-308
341. Cleveland J., Montville T.J., Nes I.F., Chikindas M.L. Bacteriocins: safe, natural antimicrobials for food preservation. Int. J. Food Microbiol. 71:2001;1-20
342. Vescovo M., Scolari G.L., Caravaggi L., Bottazzi V. Antimicrobial compounds from Lactobacillus casei and Lactobacillus helveticus. New Microbiol. 16:1993;171-175
343. Silva M., Jacobus N., Deneke C., Gorbach S.L. Antimicrobial substance from a human Lactobacillus strain. Antimicrob. Agents Chemother. 31:1987;1231-1233
344. Mcgroarty J.A., Reid G. Detection of a Lactobacillus substance that inhibits Escherichia coli. Can. J. Microbiol. 34:1988;974-978
345. Perez P.F., Minnaard J., Rouvet M., Knabenhans C., Brassart D., De Antoni G.L., Schiffrin E.J. Inhibition of Giardia intestinalis by extracellular factors from lactobacilli: an in vitro study. Appl. Environ. Microbiol. 67:2001;5037-5042
346. Lorca G.L., Wadstrom T., Valdez G.F., Ljungh A. Lactobacillus acidophilus autolysins inhibit Helicobacter pylori in vitro. Curr. Microbiol. 42:2001;39-44
347. Lesuffleur T., Barbat A., Dussaulx E., Zweibaum A. Growth adaptation to methotrexate of HT-29 human colon carcinoma cells is associated with their ability to differentiate into columnar absorptive and mucus-secreting cells. Cancer Res. 50:1990;6334-6343
348. Van Den Brink G.R., Tytgat K.M., Van Der Hulst R.W., Van Der Loos C.M., Einerhand A.W., Buller H.A., Dekker J. H. pylori colocalises with MUC5AC in the human stomach. Gut. 46:2000;601-607
349. Mukai T., Asasaka T., Sato E., Mori K., Matsumoto M., Ohori H. Inhibition of binding of Helicobacter pylori to the glycolipid receptors by probiotic Lactobacillus reuteri. FEMS Immunol. Med. Microbiol. 32:2002;105-110
350. Callewaert R., De Vuyst L. Bacteriocin production with Lactobacillus amylovorus DCE 471 is improved and stabilized by fed-batch fermentation. Appl. Environ. Microbiol. 66:2000;606-613
351. Messens W., Neysens P., Vansieleghem W., Vanderhoeven J., De Vuyst L. Modeling growth and bacteriocin production by Lactobacillus amylovorus DCE 471 in response to temperature and pH values used for sourdough fermentations. Appl. Environ. Microbiol. 68:2002;1431-1435
352. Neysens P., Messens W., De Vuyst L. Effect of sodium chloride on growth and bacteriocin production by Lactobacillus amylovorus DCE 471. Int. J. Food Microbiol. 88:2003;29-39
353. Leroy F., De Vuyst L. The presence of salt and a curing agent reduces bacteriocin production by Lactobacillus sakei CTC 494, a potential starter culture for sausage fermentation. Appl. Environ. Microbiol. 65:1999;5350-5356
354. Leroy F., De Vuyst L. A combined model to predict the functionality of the bacteriocin-producing Lactobacillus sakei strain CTC 494. Appl. Environ. Microbiol. 69:2003;1093-1099
355. Diep D.B., Myhre R., Johnsborg O., Aakra A., Nes I.F. Inducible bacteriocin production in Lactobacillus is regulated by differential expression of the pln operons and by two antagonizing response regulators, the activity of which is enhanced upon phosphorylation. Mol. Microbiol. 47:2003;483-494
356. Risoen P.A., Brurberg M.B., Eijsink V.G., Nes I.F. Functional analysis of promoters involved in quorum sensing-based regulation of bacteriocin production in Lactobacillus. Mol. Microbiol. 37:2000;619-628
357. Risoen P.A., Johnsborg O., Diep D.B., Hamoen L., Venema G., Nes I.F. Regulation of bacteriocin production in Lactobacillus plantarum depends on a conserved promoter arrangement with consensus binding sequence. Mol. Genet. Genomics. 265:2001;198-206
358. Fasano A. Cellular microbiology: can we learn cell physiology from microorganisms? Am. J. Physiol. 276:1999;C765-776
359. Uzzau S., Fasano A. Cross-talk between enteric pathogens and the intestine. Cell. Microbiol. 2:2000;83-89
360. Dramsi S., Cossart P. Intracellular pathogens and the actin cytoskeleton. Annu. Rev. Cell Dev. Biol. 14:1998;137-166
361. Bernet-Camard M.F., Coconnier M.H., Hudault S., Servin A.L. Pathogenicity of the diffusely adhering strain Escherichia coli C1845: F1845 adhesin-decay accelerating factor interaction, brush border microvillus injury, and actin disassembly in cultured human intestinal epithelial cells. Infect. Immun. 64:1996;1918-1928
362. Peiffer I., Servin A.L., Bernet-Camard M.F. Piracy of decay-accelerating factor (CD55) signal transduction by the diffusely adhering strain Escherichia coli C1845 promotes cytoskeletal F-actin rearrangements in cultured human intestinal INT407 cells. Infect. Immun. 66:1998;4036-4042
363. Peiffer I., Guignot J., Barbat A., Carnoy C., Moseley S.L., Nowicki B., Servin A.L., Bernet-Camard M.F. Structural and functionnal lesions in brush border of human polarized intestinal Caco-2/TC7 cells infected by members of the Afa/Dr diffusely adhering family of Escherichia coli. Infect. Immun. 68:2000;5979-5990
364. Peiffer I., Bernet-Camard M.F., Rousset M., Servin A.L. Impairments in enzyme activity and biosynthesis of brush border- associated hydrolases in human intestinal Caco-2/TC7 cells infected by members of the Afa/Dr family of diffusely adhering Escherichia coli. Cell. Microbiol. 3:2001;341-357
365. Lievin-Le Moal V., Amsellem R., Servin A.L., Coconnier M.H. Lactobacillus acidophilus (strain LB) from the resident adult human gastrointestinal microflora exerts activity against brush border damage promoted by a diarrhoeagenic Escherichia coli in human enterocyte-like cells. Gut. 50:2002;803-811
366. Michail S., Abernathy F. Lactobacillus plantarum inhibits the intestinal epithelial migration of neutrophils induced by enteropathogenic Escherichia coli. J. Pediatr. Gastroenterol. Nutr. 36:2003;385-391
367. Czerucka D., Rampal P. Experimental effects of Saccharomyces boulardii on diarrheal pathogens. Microbes Infect. 4:2002;733-739
368. Czerucka D., Dahan S., Mograbi B., Rossi B., Rampal P. Saccharomyces boulardii preserves the barrier function and modulates the signal transduction pathway induced in enteropathogenic Escherichia coli-infected T84 cells. Infect. Immun. 68:2000;5998-6004
369. Czerucka D., Rampal P. Effect of Saccharomyces boulardii on cAMP- and Ca2+ -dependent Cl- secretion in T84 cells. Dig. Dis. Sci. 44:1999;2359-2368
370. ′ -cyclic monophosphate induction in intestinal cells Gastroenterology. 106:1994;65-72
371. Czerucka D., Nano J.L., Bernasconi P., Rampal P. Response to cholera toxin of 2 epithelial intestinal cell lines. Effect of Saccharomyces boulardii. Gastroenterol. Clin. Biol. 13:1989;383-387
372. Dahan S., Dalmasso G., Imbert V., Peyron J.F., Rampal P., Czerucka D. Saccharomyces boulardii interferes with enterohemorrhagic Escherichia coli-induced signaling pathways in T84 cells. Infect. Immun. 71:2003;766-773
373. Desreumaux P., Colombel J.F. Intestinal flora and Crohn's disease. Ann. Pharm. Fr. 61:2003;276-281
374. Hata K., Andoh A., Sato H., Araki Y., Tanaka M., Tsujikawa T., Fujiyama Y., Bamba T. Sequential changes in luminal microflora and mucosal cytokine expression during developing of colitis in HLA-B27/beta2-microglobulin transgenic rats. Scand. J. Gastroenterol. 36:2001;1185-1192
375. Bulois P., Desreumaux P., Neut C., Darfeuille-Michaud A., Cortot A., Colombel J.F. Infectious agents and Crohn's disease. Clin. Microbiol. Infect. 5:1999;601-604
376. Langman M.J., Allan R.N. Escherichia coli for ulcerative colitis. Lancet. 354:1999;2000-2001
377. Shen W., Steinruck H., Ljungh A. Expression of binding of plasminogen, thrombospondin, vitronectin, and fibrinogen, and adhesive properties by Escherichia coli strains isolated from patients with colonic diseases. Gut. 36:1995;401-406
378. Tiveljung A., Soderholm J.D., Olaison G., Jonasson J., Monstein H.J. Presence of eubacteria in biopsies from Crohn's disease inflammatory lesions as determined by 16S rRNA gene-based PCR. J. Med. Microbiol. 48:1999;263-268
379. Schultsz C., Moussa M., Van Ketel R., Tytgat G.N., Dankert J. Frequency of pathogenic and enteroadherent Escherichia coli in patients with inflammatory bowel disease and controls. J. Clin. Pathol. 50:1997;573-579
380. Boudeau J., Glasser A.L., Masseret E., Joly B., Darfeuille-Michaud A. Invasive ability of an Escherichia coli strain isolated from the ileal mucosa of a patient with Crohn's disease. Infect. Immun. 67:1999;4499-4509
381. Boudeau J., Barnich N., Darfeuille-Michaud A. Type 1 pili-mediated adherence of Escherichia coli strain LF82 isolated from Crohn's disease is involved in bacterial invasion of intestinal epithelial cells. Mol. Microbiol. 39:2001;1272-1284
382. Darfeuille-Michaud A., Neut C., Barnich N., Lederman E., Di Martino P., Desreumaux P., Gambiez L., Joly B., Cortot A., Colombel J.F. Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. Gastroenterology. 115:1998;1405-1413
383. Hartley M.G., Hudson M.J., Swarbrick E.T., Gent A.E., Hellier M.D., Grace R.H. Adhesive and hydrophobic properties of Escherichia coli from the rectal mucosa of patients with ulcerative colitis. Gut. 34:1993;63-67
384. Masseret E., Boudeau J., Colombel J.F., Neut C., Desreumaux P., Joly B., Cortot A., Darfeuille-Michaud A. Genetically related Escherichia coli strains associated with Crohn's disease. Gut. 48:2001;320-325
385. Seksik P., Rigottier-Gois L., Gramet G., Sutren M., Pochart P., Marteau P., Jian R., Dore J. Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon. Gut. 52:2003;237-242
386. Betis F., Brest P., Hofman V., Guignot J., Bernet-Camard M.F., Rossi B., Servin A., Hofman P. The Afa/Dr adhesins of diffusely adhering Escherichia coli stimulate interleukin-8 secretion, activate mitogen-activated protein kinases, and promote polymorphonuclear transepithelial migration in T84 polarized epithelial cells. Infect. Immun. 71:2003;1068-1074
387. Tieng V., Le Bouguenec C., Du Merle L., Bertheau P., Desreumaux P., Janin A., Charron D., Toubert A. Binding of Escherichia coli adhesin AfaE to CD55 triggers cell-surface expression of the MHC class I-related molecule MICA. Proc. Natl. Acad. Sci. USA. 99:2002;2977-2982
388. Andoh A., Fujiyama Y., Sumiyoshi K., Sakumoto H., Bamba T. Interleukin 4 acts as an inducer of decay-accelerating factor gene expression in human intestinal epithelial cells. Gastroenterology. 111:1996;911-918
389. Andoh A., Fujiyama Y., Sumiyoshi K., Sakumoto H., Okabe H., Bamba T. Tumour necrosis factor-alpha up-regulates decay-accelerating factor gene expression in human intestinal epithelial cells. Immunology. 90:1997;358-363
390. Berstad A.E., Brandtzaeg P. Expression of cell membrane complement regulatory glycoproteins along the normal and diseased human gastrointestinal tract. Gut. 42:1998;522-529
391. Bjorge L., Jensen T.S., Matre R. Characterisation of the complement-regulatory proteins decay- accelerating factor (DAF, CD55) and membrane cofactor protein (MCP, CD46) on a human colonic adenocarcinoma cell line. Cancer Immunol. Immunother. 42:1996;185-192
392. Uesu T., Mizuno M., Inoue H., Tomoda J., Tsuji T. Enhanced expression of decay accelerating factor and CD59/homologous restriction factor 20 on the colonic epithelium of ulcerative colitis. Lab. Invest. 72:1995;587-591
393. Schmitt C.A., Schwaeble W., Wittig B.M., Meyer Zum Buschenfelde K.H., Dippold W.G. Expression and regulation by interferon-gamma of the membrane-bound complement regulators CD46 (MCP), CD55 (DAF) and CD59 in gastrointestinal tumours. Eur. J. Cancer. 35:1999;117-124
394. Nasu J., Mizuno M., Uesu T., Takeuchi K., Inaba T., Ohya S., Kawada M., Shimo K., Okada H., Fujita T., Tsuji T. Cytokine-stimulated release of decay-accelerating factor (DAF;CD55) from HT-29 human intestinal epithelial cells. Clin. Exp. Immunol. 113:1998;379-385
395. Gionchetti P., Amadini C., Rizzello F., Venturi A., Campieri M. Review article: treatment of mild to moderate ulcerative colitis and pouchitis. Aliment. Pharmacol. Ther. 16(Suppl. 4):2002;13-19
396. Shanahan F. Probiotics and inflammatory bowel disease: is there a scientific rationale? Inflamm. Bowel Dis. 6:2000;107-115
397. Shanahan F. Probiotics in inflamatory bowel disease. Gut. 48:2001;609
398. Shanahan F. Probiotics and inflammatory bowel disease: from fads and fantasy to facts and future. Br. J. Nutr. 88(Suppl. 1):2002;S5-S9
399. Shanahan F. Crohn's disease. Lancet. 359:2002;62-69
400. Shanahan F. Probiotics: a perspective on problems and pitfalls. Scand. J. Gastroenterol. Suppl. 2003;34-36
401. Tamboli C.P., Caucheteux C., Cortot A., Colombel J.F., Desreumaux P. Probiotics in inflammatory bowel disease: a critical review. Best Pract. Res. Clin. Gastroenterol. 17:2003;805-820
402. Madsen K.L., Doyle J.S., Jewell L.D., Tavernini M.M., Fedorak R.N. Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice. Gastroenterology. 116:1999;1107-1114
403. Schultz M., Veltkamp C., Dieleman L.A., Grenther W.B., Wyrick P.B., Tonkonogy S.L., Sartor R.B. Lactobacillus plantarum 299V in the treatment and prevention of spontaneous colitis in interleukin-10-deficient mice. Inflamm. Bowel Dis. 8:2002;71-80
404. Mccarthy J., O'mahony L., O'callaghan L., Sheil B., Vaughan E.E., Fitzsimons N., Fitzgibbon J., O'sullivan G.C., Kiely B., Collins J.K., Shanahan F. Double blind, placebo controlled trial of two probiotic strains in interleukin10 knockout mice and mechanistic link with cytokine balance. Gut. 52:2003;975-980
405. O'mahony L., Feeney M., O'halloran S., Murphy L., Kiely B., Fitzgibbon J., Lee G., O'sullivan G., Shanahan F., Collins J.K. Probiotic impact on microbial flora, inflammation and tumour development in IL-10 knockout mice. Aliment. Pharmacol. Ther. 15:2001;1219-1225
406. Madsen K., Cornish A., Soper P., Mckaigney C., Jijon H., Yachimec C., Doyle J., Jewell L., De Simone C. Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology. 121:2001;580-591
407. Dianda L., Hanby A.M., Wright N.A., Sebesteny A., Hayday A.C., Owen M.J. T cell receptor-alpha beta-deficient mice fail to develop colitis in the absence of a microbial environment. Am. J. Pathol. 150:1997;91-97
408. Li Z., Yang S., Lin H., Huang J., Watkins P.A., Moser A.B., Desimone C., Song X.Y., Diehl A.M. Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease. Hepatology. 37:2003;343-350
409. Pavan S., Desreumaux P., Mercenier A. Use of mouse models to evaluate the persistence, safety, and immune modulation capacities of lactic acid bacteria. Clin. Diagn. Lab. Immunol. 10:2003;696-701
410. Shibolet O., Karmeli F., Eliakim R., Swennen E., Brigidi P., Gionchetti P., Campieri M., Morgenstern S., Rachmilewitz D. Variable response to probiotics in two models of experimental colitis in rats. Inflamm. Bowel Dis. 8:2002;399-406
411. Dieleman L.A., Goerres M.S., Arends A., Sprengers D., Torrice C., Hoentjen F., Grenther W.B., Sartor R.B. Lactobacillus GG prevents recurrence of colitis in HLA-B27 transgenic rats after antibiotic treatment. Gut. 52:2003;370-376
412. Floch M.H. Probiotics, irritable bowel syndrome, and inflammatory bowel disease. Curr. Treat. Options Gastroenterol. 6:2003;283-288
413. Bianchi-Salvadori B., Vesely R., Ferrari A., Canzi E., Casiraghi C., Brighenti F. Behaviour of the pharmaceutical probiotic preparation VSL#3 in human ileostomy effluent containing its own natural elements. New Microbiol. 24:2001;23-33
414. Brigidi P., Swennen E., Vitali B., Rossi M., Matteuzzi D. PCR detection of Bifidobacterium strains and Streptococcus thermophilus in feces of human subjects after oral bacteriotherapy and yogurt consumption. Int. J. Food Microbiol. 81:2003;203-209
415. Venturi A., Gionchetti P., Rizzello F., Johansson R., Zucconi E., Brigidi P., Matteuzzi D., Campieri M. Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis. Aliment. Pharmacol. Ther. 13:1999;1103-1108
416. Kim H.J., Camilleri M., Mckinzie S., Lempke M.B., Burton D.D., Thomforde G.M., Zinsmeister A.R. A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome. Aliment. Pharmacol. Ther. 17:2003;895-904
417. Malin M., Suomalainen H., Saxelin M., Isolauri E. Promotion of IgA immune response in patients with Crohn's disease by oral bacteriotherapy with Lactobacillus GG. Ann. Nutr. Metab. 40:1996;137-145
418. Guandalini S. Use of Lactobacillus-GG in paediatric Crohn's disease. Dig. Liver Dis. 34(Suppl. 2):2002;S63-S65
419. Prantera C., Scribano M.L. Probiotics and Crohn's disease. Dig. Liver Dis. 34(Suppl. 2):2002;S66-67
420. Halpern G.M., Prindiville T., Blankenburg M., Hsia T., Gershwin M.E. Treatment of irritable bowel syndrome with Lacteol Fort: a randomized, double-blind, cross-over trial. Am. J. Gastroenterol. 91:1996;1579-1585
421. Bulois P., Tremaine W.J., Maunoury V., Gambiez L., Hafraoui S., Leteurtre L., Cortot A., Sandborn W.J., Colombel J.F., Desreumaux P. Pouchitis is associated with mucosal imbalance between interleukin-8 and interleukin-10. Inflamm. Bowel Dis. 6:2000;157-164
422. Gionchetti P., Rizzello F., Venturi A., Brigidi P., Matteuzzi D., Bazzocchi G., Poggioli G., Miglioli M., Campieri M. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology. 119:2000;305-309
423. Sandborn W.J., Mcleod R., Jewell D.P. Medical therapy for induction and maintenance of remission in pouchitis: a systematic review. Inflamm. Bowel Dis. 5:1999;33-39
424. Sandborn W., Mcleod R., Jewell D. Pharmacotherapy for inducing and maintaining remission in pouchitis. Cochrane Database Syst. Rev. CD001176. 2000
425. Kuisma J., Mentula S., Jarvinen H., Kahri A., Saxelin M., Farkkila M. Effect of Lactobacillus rhamnosus GG on ileal pouch inflammation and microbial flora. Aliment. Pharmacol. Ther. 17:2003;509-515
426. Hancock R.E., Patrzykat A. Clinical development of cationic antimicrobial peptides: from natural to novel antibiotics. Curr. Drug Targets Infect. Disord. 2:2002;79-83
427. Koczulla A.R., Bals R. Antimicrobial peptides: current status and therapeutic potential. Drugs. 63:2003;389-406
428. Sitaram N., Nagaraj R. The therapeutic potential of host-defense antimicrobial peptides. Curr. Drug Targets. 3:2002;259-267
429. Van 'T Hof W., Veerman E.C., Helmerhorst E.J., Amerongen A.V. Antimicrobial peptides: properties and applicability. Biol. Chem. 382:2001;597-619
430. Zasloff M. Antimicrobial peptides in health and disease. N. Engl. J. Med. 347:2002;1199-1200
431. Huang H.W. Peptide-lipid interactions and mechanisms of antimicrobial peptides. Novart. Found. Symp. 225:1999;188-200
432. Shai Y. Mode of action of membrane active antimicrobial peptides. Biopolymers. 66:2002;236-248
433. Helander I.M., Mattila-Sandholm T. Permeability barrier of the gram-negative bacterial outer membrane with special reference to nisin. Int. J. Food Microbiol. 60:2000;153-161
434. Moll G.N., Konings W.N., Driessen A.J. Bacteriocins: mechanism of membrane insertion and pore formation. Antonie Van Leeuwenhoek. 76:1999;185-198
435. Chauviere G., Coconnier M.H., Kerneis S., Darfeuille-Michaud A., Joly B., Servin A.L. Competitive exclusion of diarrheagenic Escherichia coli (ETEC) from human enterocyte-like Caco-2 cells by heat-killed Lactobacillus. FEMS Microbiol. Lett. 70:1992;213-217
436. Shu Q., Gill H.S. Immune protection mediated by the probiotic Lactobacillus rhamnosus HN001 (DR20) against Escherichia coli O157:H7 infection in mice. FEMS Immunol. Med. Microbiol. 34:2002;59-64
437. Nagao F., Nakayama M., Muto T., Okumura K. Effects of a fermented milk drink containing Lactobacillus casei strain Shirota on the immune system in healthy human subjects. Biosci. Biotechnol. Biochem. 64:2000;2706-2708